Cardiogenic shock remains one of the most complex and life-threatening conditions in cardiovascular medicine, associated with persistently high morbidity and mortality.
Recognising the urgent need for structured, high-quality education, ACVC and EAPCI have joined forces to create this new School.
This collaboration introduces an innovative, two-tiered educational programme.
To ensure tailored and impactful learning, the programme is split into two complementary courses per year, each meeting distinct levels of expertise and educational needs:
- Level 1 (Paris, France - 2025) is designed for physicians new to mechanical circulatory support (MCS) or those introducing these technologies in their centres. This course provides a strong foundation in the principles of cardiogenic shock management and MCS initiation.
- Level 2 (Barcelona, Spain - 2026) is tailored for experienced clinicians who already manage cardiogenic shock patients and seek advanced insights into complex decision-making, clinical case simulation, hands-on escalation strategies, and MCS techniques.
Level 1 is now open!
When: 8–9 September 2025
Where: Hotel Pullman Montparnasse, Paris
Target audience
Physicians new to mechanical circulatory support (MCS) and those introducing these technologies in their centres.
Learning objectives
A curriculum built around expert-led lectures, case-based discussions, hands-on simulations, and interactive workshops, to learn how to:
- Gain fundamental theoretical knowledge about cardiogenic shock, including its pathophysiology and classification.
- Engage in clinical case scenario discussions to enhance decision-making skills.
- Participate in hands-on sessions with simulators for mechanical circulatory support (MCS) placement and management.
- Develop competency in stratification and phenotypisation of cardiogenic shock.
- Master ICU management strategies, including weaning from MCS and escalation and handling complications.
- Understand advanced haemodynamic monitoring techniques and pharmacologic management.
- Gain expertise in MCS implantation techniques and their indications in various clinical settings.
Registration fees (including VAT)
- Non ACVC/EAPCI Member: €670
- ACVC/EAPCI Member: €570
- ACVC/EAPCI Young Member: €470
Hotel
You benefit from a preferential rate at Paris Pullman Montparnasse if you register to the course.
Our mission: To reduce the burden of cardiovascular disease.